Cryo-Cell International, Inc.
NASDAQ:CCEL
4.3199 (USD) • At close September 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue
| 31.986 | 31.344 | 30.337 | 28.885 | 31.148 |
| Cost of Revenue
| 7.948 | 8.442 | 8.792 | 8.99 | 9.657 |
| Gross Profit
| 24.038 | 22.901 | 21.544 | 19.895 | 21.49 |
| Gross Profit Ratio
| 0.752 | 0.731 | 0.71 | 0.689 | 0.69 |
| Reseach & Development Expenses
| 1.243 | 1.171 | 0.385 | 0.05 | 0.024 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.521 | 17.116 | 15.58 | 14.625 | 14.294 |
| Other Expenses
| 0.794 | 16.918 | 1.12 | 0.835 | 0.166 |
| Operating Expenses
| 20.558 | 35.205 | 17.085 | 15.51 | 14.485 |
| Operating Income
| 3.48 | -12.304 | 4.024 | 4.003 | 7.662 |
| Operating Income Ratio
| 0.109 | -0.393 | 0.133 | 0.139 | 0.246 |
| Total Other Income Expenses Net
| -0.676 | -1.06 | -0.706 | -1.407 | -2.622 |
| Income Before Tax
| 2.804 | -13.364 | 3.319 | 2.611 | 5.039 |
| Income Before Tax Ratio
| 0.088 | -0.426 | 0.109 | 0.09 | 0.162 |
| Income Tax Expense
| 2.402 | -3.843 | 0.548 | 0.528 | 1.415 |
| Net Income
| 0.402 | -9.522 | 2.771 | 2.084 | 3.625 |
| Net Income Ratio
| 0.013 | -0.304 | 0.091 | 0.072 | 0.116 |
| EPS
| 0.05 | -1.14 | 0.33 | 0.26 | 0.48 |
| EPS Diluted
| 0.05 | -1.14 | 0.33 | 0.25 | 0.45 |
| EBITDA
| 1.423 | -10.417 | 6.65 | 5.317 | 7.219 |
| EBITDA Ratio
| 0.044 | -0.332 | 0.219 | 0.184 | 0.232 |